Results 221 to 230 of about 1,023,256 (260)

Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?

, 2020
Vladimir N. Uversky, Fatma Elrashdy, Abdullah A. Aljadawi, Syed Moasfar Ali, Rizwan Hasan Khan, Elrashdy M. Redwan   +5 more
openalex   +1 more source

Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following Prior Infection or Vaccination. [PDF]

J Infect Dis
Ebinger JE, Sun N, Joung SY, Sanchez JMS, Wang M, Liu Y, Prostko JC, Frias EC, Stewart JL, Heath M, Claggett BL, Cheng S, Sobhani K.   +12 more
europepmc   +1 more source

A First Case Report of Autoimmune Acquired Factor V Deficiency After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination at the Time of Initiating Haemodialysis. [PDF]

Nephrology (Carlton)
Tasaki A, Fukuda A, Kudo A, Nishikawa E, Koumatsu N, Wada M, Okita J, Maruo M, Uchida H, Nakata T, Itani K, Shibata H.   +11 more
europepmc   +1 more source

Increased pathogenicity and transmissibility in hamsters of all age groups reveal an underestimated perniciousness of severe acute respiratory syndrome coronavirus 2 EG.1 variant. [PDF]

iScience
Zhou M, Ma J, Fang M, Liu X, Zhang C, Wu K, Ye J, Zhang Y, Yuan Q, Chen R, Chen P, Zhu H, Guan Y, Cheng T, Yuan L, Xia N.   +15 more
europepmc   +1 more source

A population-representative serosurvey estimating vaccine-induced immunity against measles, rubella, hepatitis B and severe acute respiratory syndrome coronavirus 2 in Timor-Leste. [PDF]

Lancet Reg Health Southeast Asia
Arkell P, Tanesi MY, Martins N, Gomes N, Oakley T, Solano V, David M, Amaral S, Sheridan SL, Yip TW, Draper ADK, Sarmento N, Soares da Silva E, Alves L, Nicholson S, Stambos V, Pedrina K, Freitas C, de Neri Machado F, Gusmão CA, da Costa Barreto I, Fancourt NSS, Macartney K, Yan J, Francis JR.   +24 more
europepmc   +1 more source

In silico exploration of natural xanthone derivatives as potential inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication and cellular entry. [PDF]

J Comput Aided Mol Des
Obakachi VA, Nchiozem-Ngnitedem VA, Govender KK, Govender PP.   +3 more
europepmc   +1 more source

Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses. [PDF]

PLoS Pathog
Gilbert-Girard S, Piret J, Carbonneau J, Hénaut M, Goyette N, Boivin G.   +5 more
europepmc   +1 more source

Current development of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (Review). [PDF]

Mol Med Rep
Zhang T, Yang D, Tang L, Hu Y.
europepmc   +1 more source

BCG-Induced DNA Methylation Changes Improve Coronavirus Disease 2019 Vaccine Immunity Without Decreasing the Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection. [PDF]

Open Forum Infect Dis
Carrero Longlax S, Koster KJ, Kamat AM, Lozano M, Lerner SP, Hannigan R, Nishiguchi T, Abhimanyu, Sheikh D, Ladki M, Portillo A, Koirala A, Patel TD, Spieler Z, Benjamin AB, Lebedev M, Ofili TU, Hutchison RW, Udeani G, Opperman LA, Neal G, Mandalakas AM, Netea MG, Arditi M, Avalos P, Grimm SL, Coarfa C, Cirillo JD, DiNardo AR.   +28 more
europepmc   +1 more source

Positive impact of nutrition in the prevention of peripheral vascular disease and severe acute respiratory syndrome coronavirus 2: review. [PDF]

Front Nutr
Karim ZA, Reese RA, Smith AN, Blackadar ME, Arora V, Moore NM, Johnson EA.   +6 more
europepmc   +1 more source